Dr. Javier Antonio Leon, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 404 Calle La Rabida, San Juan, PR 00918 Phone: 787-771-9119 |
Alexandra Acevedo Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 504 Ave Hostos, San Juan, PR 00918 Phone: 787-525-5554 |
News Archive
People who survive a stroke in their 40s, 50s or early 60s may still have decades to live – but only if they take blood thinners, blood pressure drugs and other medications that can reduce their risk of a second stroke.
Just in time for the holidays, McGill researchers have identified a new way to reduce fat and cholesterol levels in the body. Their program, which combines consuming plant-derived sterols (or oils) with exercise, may benefit those who are at risk of coronary heart disease.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
Children who suffer from Hutchinson-Gilford Progeria syndrome age prematurely due to a defective protein in their cells. Scientists at Technische Universität München have now identified another important pathological factor: the system responsible for removing cellular debris and for breaking down defective proteins operates at lower levels in HGPS cells than in normal cells. The researchers have succeeded in reactivating protein breakdown in HGPS cells and thus reducing disease-related defects by using a substance from broccoli.
› Verified 2 days ago